Navigation Links
New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins

Researchers from Germany have discovered a novel, less invasive imaging technique for visualization of coronary veins. This technique, called ECG-gated cardiac modified discrete cosine transform, or MDCT, is associated with very few complications // . It is further believed to result in an improved diagnostic quality and treatment.

A comparison of the new technique with conventional angiography revealed a superior performance. It is perceived as a boon "for individuals undergoing surgical procedures on the heart and particularly the coronary veins," by Aachen University Hospital researchers.

An adequate or rather a complete knowledge of the cardiac anatomy is a prerequisite for optimal planning of the proposed treatment. Moreover, the variability of the coronary veins with respect to the number, caliber and course makes the clinical assessment rather difficult. This difficulty can be surpassed with the new technique is used. The results of the study can be found in the American Journal of Roentgenology.

"MDCT angiography is a reliable alternative to invasive conventional coronary angiography, and should be used to evaluate the coronary veins prior to pacemaker lead placement, and other procedures. MDCT angiography improves the quality of diagnosis and treatment for the patient by providing better planning of the procedure prior to surgery such as pacemaker placement," said lead author Dr. Georg Muhlenbruch.


'"/>




Page: 1

Related medicine news :

1. Cardiac diseases develop early
2. Heart problems detected better with a Cardiac MRI
3. Cardiac events better treated with intense cholesterol-lowering regime
4. Sudden Cardiac Death due to inherited Heart Disease
5. Vasopressin Found To Boost Survival In Sudden Cardiac arrest
6. Stem Cells From Bone Marrow Found To Improve Cardiac Functioning After A Heart Attack
7. Cardiac – Rehabilitation Programs Beneficial for Heart Patient
8. Cardiac Valve Disease Linked To Genes
9. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
10. Prevent Cardiac Problems And Laugh Your Way To Good Health
11. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
Post Your Comments:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
... the first time issued Global Air Quality Guidelin...ollution that kills 2 million// people each year w...ntries. The WHO appealed to governments to enhanc...nt issued by the WHO's regional office in Manila r...
...s to unraveling the mystery of the disease best kn...an Lou Gehrig nearly 70 years ago//. According to ...ania a team of researchers has identified the misf...g's disease or amyotrophic lateral sclerosis (ALS)...
...are going full steam to counter skin diseases tha...ent the spread of tinea(fungal infections),scabies... among infants living in the ,far flung interior a...timely and effective treatment for the same. Pov...
...er in Bihar with the detection of new cases in tho... immunisation drive this year//. Eight districts o...r the drive.Two new polio cases were detected in J...al and Nawada districts. Patna district has also f...
Other Medicine News:Health News:Clues to the Mystery of Lou Gehrig's Disease 2
(Date:10/10/2008)... SWARTZ CREEK, Mich., Oct. 10 /- D...va Neuroscience has selected Diplomat,Specialty Ph...e in a large,scale, national Therapy Optimization ... of the two year TOP MS study, is to examine the b... program on compliance, adherence and,patient outc...
(Date:10/10/2008)... PLEASANTON, Calif., Oct. 10 /- Tr...as been authorized to affix the CE (Conformite,Eur...ntares(TM) Coronary,Stent System, a unique main ve... near coronary bifurcations., Representing the ne...(TM) system has potential use in a quarter of the ...
(Date:10/9/2008)... Top Line Clinical Results Expected in November...ll/ -- SCOLR Pharma, Inc.,(Amex: DDD ) announced ...ing,for the third of its three pivotal trials to e... of 12-hour extended-release (ER) ibuprofen for,th...ts to report top-line,results from this pivotal tr...
(Date:10/8/2008)... Acceptance Will Reduce Animal Use in Cosmetics...RNewswire/ -- MatTek Corp. today announced,that re...i-laboratory,"catch-up" validation study on MatTek...The test results demonstrated the required sensiti... a validated alternative to animal,testing for det...
Breaking Medicine Technology:Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Muscular Dystrophy Treatment Shows Promise 6450 1Muscular Dystrophy Treatment Shows Promise 6450 2Muscular Dystrophy Treatment Shows Promise 6450 3Granger wins Schmidt Nielsen Mentor Scientist Award 1243 1Granger wins Schmidt Nielsen Mentor Scientist Award 1243 2USP announces 11 new proposed monographs for dietary supplements 6444 1USP announces 11 new proposed monographs for dietary supplements 6444 2Medical Services Gets Significant Interest in Its Dual VScan Test Kit 6440 1Medical Services Gets Significant Interest in Its Dual VScan Test Kit 6440 2
...cer drug developer Antisoma plc,(LSE: ASM, US OTC:... trial of ASA404 in recurrent, platinum-sensitive ...ving ASA404 plus chemotherapy,(n=37) with patients...dings are as follows: , * There was no advantage i...arm compared with the control arm * One-year survi...
...RNewswire-FirstCall/ -- ImClone,Systems Incorporat...d results from an open-label Phase III study of ER... in the first-line,treatment for metastatic non-sm...et its primary endpoint of progression-free,surviv...eview,committee (IRRC). However, key secondary end...
Other Medicine Technology:Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 2Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 2Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 4Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 5Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 6Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 7Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 8Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 9
The Bio-Quant TROPONIN I test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of cardiac,troponin I (cTnI) in human serum specimens as an aid i
...or many patients with a diseased heart, the only t...t transplant. However, donor organs are not always...le die while they are on the waiting list for a do... devices (VAD) can save the life of a patient. On ...
...nstaTest AFP is an immunochromatographic in vitro ...n human serum. AFP is a protein with molecular mas...entration in serum is below 9 ng/mL; higher concen... testicular and presacral teratocarcinomas, and ot...
STA Compact is a fully automated random access coagulation analyser for clotting, photometric and immunological, latex based .coagulation tests.The medium-throughput analyser offers continous loading
Medicine Products: